胰腺炎相关假性动脉瘤的血管内与经皮经腹栓塞治疗:三级转诊中心经验
回顾性分析2014年1月至2019年3月因胰腺炎相关假性动脉瘤接受栓塞治疗的80例患者,CTA在65例(81.2%)中检出假性动脉瘤,最常见部位为胃十二指肠动脉,其次为脾动脉。经皮凝血酶注射的技术成功率为4/7(57%),经皮胶栓塞为5/5(100%),血管内栓塞为68/68(100%)。作者结论认为血管内或经皮栓塞技术成功率高且安全性良好。
要点
- 胰腺炎相关假性动脉瘤最常见于胃十二指肠动脉,其次为脾动脉。
- CTA在81.2%(65/80)的患者中检出假性动脉瘤。
- 血管内栓塞技术成功率为68/68(100%),经皮胶栓塞为5/5(100%),经皮凝血酶注射为4/7(57%)。
关键影像表现/征象
- 假性动脉瘤与慢性胰腺炎相关者44例(55%),与急性胰腺炎相关者36例(45%)。
- 假性动脉瘤在CTA上检出65例(81.2%)。
- 假性动脉瘤最常见部位为胃十二指肠动脉,其次为脾动脉。
诊断标准与关键数值
- 技术成功:经皮凝血酶注射组4/7(57%),经皮胶注射组5/5(100%),血管内栓塞组68/68(100%)。
临床应用与阅片要点
- 7例在超声或透视引导下行经皮凝血酶注射,5例行经皮胶注射,其余68例行导管造影及血管内栓塞。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To analyse the technical challenges, clinical success, and associated complications of endovascular and percutaneous embolisation of pancreatitis-related pseudoaneurysms.
MATERIALS AND METHODS: A retrospective study of patients referred for embolisation of pancreatitis-related pseudoaneurysms between January 2014 and March 2019 was conducted. Computed tomography angiography (CTA) was performed to assess the morphology of the aneurysms prior to any intervention. Percutaneous or endovascular embolisation was performed. Details of CTA and methods of embolisation were recorded. Technical success, clinical success, and complications were reported.
RESULTS: A total of 80 patients (mean age, 40.69 ± 13.41 years, 73 male) underwent embolisation during the study period. Pseudoaneurysms were related to chronic pancreatitis (CP) in 44 (55%) patients and acute pancreatitis (AP) in 36 (45%) patients. Pseudoaneurysms were detected in 65 (81.2%) patients on CTA. The most common site of pseudoaneurysms was gastroduodenal artery (GDA) followed by splenic artery. Seven patients were treated with percutaneous thrombin injection and five were treated with percutaneous glue injection under ultrasound/fluoroscopy guidance. The remaining patients (n=68) underwent catheter angiography with endovascular embolisation. Technical success was achieved in 4/7 (57%) percutaneous thrombin cases and in all the cases (5/5, 100%) with percutaneous glue or endovascular (68/68,100%) embolisation.
CONCLUSION: Endovascular or percutaneous embolisation of pseudoaneurysms has high technical success with an excellent safety profile.
引用
- Gorsi U, Agarwal V, Nair V, et al. Endovascular and percutaneous transabdominal embolisation of pseudoaneurysms in pancreatitis: an experience from a tertiary-care referral centre. Clin Radiol. 2021. PMID: 33526255. doi:10.1016/j.crad.2020.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。